![Alfredo Zurlo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alfredo Zurlo
No open positions remaining
Profile
Alfredo Zurlo served as Co-Managing Director at Glycotope GmbH.
He then worked as Chief Medical Officer at MOLOGEN AG from 2013 to 2016.
After that, he served as Chief Medical Officer at Scandion Oncology A. Zurlo holds a doctorate degree from The American University of Rome.
Former positions of Alfredo Zurlo
| Companies | Position | End |
|---|---|---|
| MOLOGEN AG | Chief Tech/Sci/R&D Officer | 31/03/2016 |
| SCANDION ONCOLOGY A/S | Chief Tech/Sci/R&D Officer | - |
Glycotope GmbH
 Glycotope GmbH Data Processing ServicesTechnology Services Provides hosting, web development and UX design services | Chief Executive Officer | - |
Training of Alfredo Zurlo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
The American University of Rome
 The American University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MOLOGEN AG
 MOLOGEN AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for the treatment of infectious diseases | Health Technology |
Glycotope GmbH
Glycotope GmbH Data Processing ServicesTechnology Services Provides hosting, web development and UX design services | Technology Services |
Scandion Oncology A/S
 Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
- Stock Market
- Insiders
- Alfredo Zurlo
